Cefdinir-¹³C,¹⁵N₂  (Synonyms: FK-482-¹³C,¹⁵N₂; CI-983-¹³C,¹⁵N₂)

Cefdinir-¹³C,¹⁵N₂ (FK-482-¹³C,¹⁵N₂) is ¹³C and ¹⁵N labeled Cefdinir. Cefdinir (FK-482) is a semi-synthetic, broad-spectrum antibiotic in the third generation of the cephalosporin class, which is proved to be effective for infections caused by several Gram-negative and Gram-positive bacteria. Cefdinir can be used for the research of common bacterial infections of the ear, sinus, throat, and skin^[1][2].

398.39

C₁₃¹³CH₁₃N₃¹⁵N₂O₅S₂

91832-40-5

O=C(C(N12)=C(C=C)CS[C@]2([H])[C@H](NC(/C(C3=CS[13C]([15NH2])=[15N]3)=N\O)=O)C1=O)O

Room temperature in continental US; may vary elsewhere.

Please store the product under the recommended conditions in the Certificate of Analysis.

• [1]. Russak EM, et al. Impact of Deuterium Substitution on the Pharmacokinetics of Pharmaceuticals. Ann Pharmacother. 2019 Feb;53(2):211-216.  [Content Brief]

  [2]. Soejima R. Cefdinir. Jpn J Antibiot. 1992 Oct;45(10):1239-52.  [Content Brief]

  [3]. Labro MT, et al. Cefdinir (CI-983), a new oral amino-2-thiazolyl cephalosporin, inhibits human neutrophil myeloperoxidase in the extracellular medium but not the phagolysosome. J Immunol. 1994 Mar 1;152(5):2447-55.  [Content Brief]